erms are used illustratively to comply with FINRA regulation. 102 COWEN.COM HOUSE_OVERSIGHT_024918 COWEN COLLABORATIVE INSIGHTS February 25, 2019 GW Pharmaceuticals Ple Rating History as of 02/25/2019 powered by: BlueMatrix (1):$166.00 || (1):$165.00 || (1):$175.00 02/24/17 08/07/17 09/27/18 180 160 140 120 100 80 60 40 20 Apr